Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and … - GlobeNewsWire (press release)
|
Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and …
GlobeNewsWire (press release), CA Hedrin is a next generation, non-pesticide treatment for head lice and is currently being developed as a 1-hour head lice treatment by and through a joint venture with Nordic Biotech. Hedrin was designated as a Class III medical device by the Food and … |